TITLE

Stem cell patenting

AUTHOR(S)
Baldock, Claire
PUB. DATE
January 2006
SOURCE
Journal of Commercial Biotechnology;Jan2006, Vol. 12 Issue 2, p120
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The patenting of embryonic stem cell-related inventions appears to be as controversial as the technology itself. The author outlines the state of play in Europe and the USA as well as other selected territories. While Europe has the broadest statutory exclusions to patenting of inventions which might be regarded as unethical, it appears that a smooth ride for applicants and patent holders is not guaranteed elsewhere.
ACCESSION #
20197674

 

Related Articles

  • Embryonic Stem Cell Patents and Human Dignity. David Resnik // Health Care Analysis;Sep2007, Vol. 15 Issue 3, p211 

    Abstract  This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent...

  • The Basics About Stem Cells. Condic, Maureen L. // Human Life Review;Winter/Spring2002, Vol. 28 Issue 1/2, p119 

    Discusses issues pertaining to research on embryonic stem cells. Questions raised by the use of human embryos in medical research; Scientific arguments against the use of embryonic stem cells as a treatment for disease and injury; Advantages of using adult stem cells for research.

  • Patent watch.  // Nature Reviews Drug Discovery;Oct2002, Vol. 1 Issue 10, p750 

    Reports on developments concerning patents in Europe and the United States as of October 2002. Oral proceedings of the Opposition Division of the European Patent Office concerning the use of genetic engineering to isolate stem cells from more differentiated cells to obtain pure stem-cell...

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

  • Humane embryonale Stammzellforschung -- vom Diskurs über den Status des Embryos bis zu praktischen rechtlichen Lösungen der EU-Mitgliedstaaten. Druml, Christiane; Wolfslehner, Doris // OZP-Oesterreichische Zeitschrift für Politikwissenschaft;2011, Vol. 40 Issue 1, p67 

    The article analyses the reports and opinions of the National Bioethics Commissions of the EU-15 regarding human embryonic stem cell research (hES). It argues that although the overall structure of these reports and opinions is quite homogeneous, dealing with scientific, legal and ethical...

  • Five Framings -- One Entity? The Political Ethics of Human Embryonic Stem Cells. Nielsen, Torben Hviid // Science Studies;Jun2005, Vol. 18 Issue 1, p30 

    Following their initial derivation in 1998, human embryonic stem cells have been presented in five dominant framings. The original framings as a breakthrough in basic research and a medical hope were both intended and orchestrated to anticipate and overrule the old bioethical concerns. The third...

  • New life at the expense of another. Pickup, Mark // Human Life Review;Winter2000, Vol. 26 Issue 1, p109 

    Focuses on the use of human embryonic stem cells to arrest debilitating diseases in Canada. Efforts of American and German researchers in obtaining embryonic stem cells from animal models; Statistics on stem-cell transplants for multiple sclerosis; Moral and ethical concerns of stem cell...

  • Pro-life and anti-ethics. Grayling, A. C. // New Scientist;12/22/2007, Vol. 196 Issue 2635/2636, p76 

    The author asserts that the use of embryonic stem cells in medical research is pro-life, in that the use of potential life is used to further the cures of people already alive. A discussion of the the use of the 30 cells in a blastocyst, which are surplus after in-vitro fertilization processes,...

  • French ethics law revised. Louët, Sabine // Nature Biotechnology;Jan2001, Vol. 19 Issue 1, p6 

    Reports that French government has proposed changes to its 1994 Bioethics law to allow research on human embryos and facilitate the development of therapies from work from embryonic stem cells (ESC). Provision to derive stem cells from embryos leftover from in vitro fertilization procedures;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics